CDC’s Vaccine-Efficacy Epidemiologic Incompetence

CDC’s Vaccine-Efficacy Epidemiologic Incompetence
chemical industry/Shutterstock
Harvey Risch
Updated:
0:00
Commentary

Periodically during the COVID-19 pandemic, CDC scientific staff have employed their available studies’ data to estimate the efficacy of current or recent versions of COVID-19 vaccines to reduce risk of testing positive for COVID-19. While the fact of “testing positive” has been somewhat controversial because of the secret PCR Ct threshold numbers involved that have allowed for uninfectious people with unrecognized COVID-19 from some weeks in the past to remain test-positive, my goal here is to illustrate CDC’s problematic epidemiologic methods that have substantially inflated the vaccine efficacy percents that they have reported.

Harvey Risch
Harvey Risch
Author
Dr. Harvey Risch is professor of epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine. He received his M.D. from the University of California–San Diego and Ph.D. from the University of Chicago. After serving as a postdoctoral fellow in epidemiology at the University of Washington, Risch was a faculty member in epidemiology and biostatistics at the University of Toronto before coming to Yale.
Related Topics